Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04143711
Title Study of DF1001 in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Dragonfly Therapeutics

urethra transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

ureter transitional cell carcinoma

Advanced Solid Tumor

breast cancer



DF1001 + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA | FRA | BEL

No variant requirements are available.